Table 1.
Relationship between LINC00152 expression and clinicopathological characteristics of LAD patients
| Characteristics | N (%) | linc00152 | linc00512 | P |
|---|---|---|---|---|
| High | Low | Chi-square | ||
| d-test | ||||
| P-value | ||||
| Age (years) | 0.436 | |||
| > 65 | 27 (45%) | 12 | 15 | |
| ≤ 65 | 33 (55%) | 18 | 15 | |
| Gender | 0.598 | |||
| Male | 24 (40%) | 13 | 11 | |
| Female | 36 (60%) | 17 | 19 | |
| TNM stage | 0.035* | |||
| I + II | 24 (40%) | 8 | 16 | |
| IIIa | 36 (60%) | 22 | 14 | |
| Tumor size | 0.020* | |||
| ≤ 5 | 16 (26.7%) | 4 | 12 | |
| > 5 | 44 (73.3%) | 26 | 18 | |
| Lymph node metastasis | 0.001* | |||
| Negative | 22 (36.7%) | 5 | 17 | |
| Positive | 38 (63.3%) | 25 | 13 | |
| Smoking history | 0.301 | |||
| Smokers | 28 (46.7%) | 16 | 12 | |
| Never smoker | 32 (53.3%) | 14 | 18 |
*P < 0.05